Dr. Yancy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
676 North St. Clair
suite 600
Chicago, IL 60611Phone+1 312-926-2492Fax+1 312-694-9430
Summary
- Dr. Clyde Yancy is a cardiologist in Chicago, IL and is affiliated with Northwestern Memorial Hospital. He received his medical degree from Tulane University School of Medicine and has been in practice 35 years. He specializes in prevention, heart failure, cardiomyopathies, heart transplantation, health disparities, health policy, outcomes research, and diversity/equity/inclusion. He is a recognized national leader in cardiovascular medicine.
Education & Training
- University of TexasMSc, Medical Management, 2008 - 2010
- University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 1986 - 1987
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1982 - 1985
- Tulane University School of MedicineClass of 1982
Certifications & Licensure
- IL State Medical License 2011 - 2026
- TX State Medical License 1984 - 2024
- LA State Medical License 1982 - 2009
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- President American Heart Association, 2009-2010
- Super Doctor SuperDoctors.com
- Whos Who in Medicine and Healthcare Marquis Whos Who
- Join now to see all
Clinical Trials
- IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting Start of enrollment: 2005 May 01
- AC6 Gene Transfer for CHF Start of enrollment: 2010 Jul 01
Publications & Presentations
PubMed
- Angiotensin Receptor-Neprilysin Inhibitor Prescribing Patterns in Patients Hospitalized for Heart Failure.Pratyaksh K Srivastava, Alexandra M Klomhaus, Stephen J Greene, Paul Heidenreich, Sabra C Lewsey
JAMA Cardiology. 2024-12-11 - Global Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure.Amber B Tang, Boback Ziaeian, Javed Butler, Clyde W Yancy, Gregg C Fonarow
JAMA Cardiology. 2024-12-01 - Sex-Specific Efficacy and Safety in HF Trials: Inclusion Is Only the First Step.Sadiya Khan, Clyde W Yancy, Gregg C Fonarow
JAMA Cardiology. 2024-11-17
Journal Articles
- Expediting the Benefits of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure—There Is No Time for DelayGregg C Fonarow, Clyde W Yancy, JAMA Cardiology
- Association of the V122I Transthyretin Amyloidosis Genetic Variant with Cardiac Structure and Function in Middle-Aged Black AdultsClyde W Yancy, Elizabeth M Mcnally, Joao Lima, Donald M Lloyd-Jones, Sadiya S Khan, JAMA Cardiology
- Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients with High-Risk Cardiovascular...Jacob A Udell, Sheila M Hegde, Deepak L Bhatt, J Michael Gaziano, Kristin Nichol, Matthew C Tattersall, Jonathan L Temte, Clyde Yancy, JAMA
- Join now to see all
Lectures
- Diversity in Medicine: Charting a Path ForwardCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
- Challenges in Heart Failure: Diagnosis and Management2019 ACP Internal Medicine Meeting, Philadelphia - 4/13/2019
- Kanu and Docey Chatterjee Keynote and Seminal Talks in Heart Failure: Guidelines Challenges and Pathway for Success: Learn from the Experts2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Join now to see all
Authored Content
- Cardiology and COVID-19September 2020
- Explanation for the Corrections for the Study of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019August 2020
- Explanation for the Corrections for the Study of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019August 2020
- The Use of Sacubitril/Valsartan for Hospitalized Heart Failure—Why Do We Care About Cost and Value?August 2020
- The Use of Sacubitril/Valsartan for Hospitalized Heart Failure—Why Do We Care About Cost and Value?August 2020
- Coronavirus Disease 2019 (COVID-19) and the Heart—Is Heart Failure the Next Chapter?July 2020
- Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy with Outcome for Patients with Heart FailureMay 2020
- 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure with Reduced Ejection Fraction A Report of the American College of Cardiology Task Force on Expert Consensus Decision PathwaysJanuary 2018
- 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure with Reduced Ejection FractionDecember 2017
- Join now to see all
Press Mentions
- ACCEL Lite: Top Takeaways from 2024: Heart Failure with Clyde W. Yancy, MD, MACCDecember 12th, 2024
- Redlining: Heart Disease More Common in Past Redlined Areas Linked to Limited Access to Healthy FoodsNovember 25th, 2024
- GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?November 13th, 2024
- Join now to see all
Committees
- member, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
Professional Memberships
- Fellow
- Fellow
- Master
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: